Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rad21
|
ENSMUSG00000022314.9 | RAD21 cohesin complex component |
Smc3
|
ENSMUSG00000024974.10 | structural maintenance of chromosomes 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_51992067_51992235 | Rad21 | 404 | 0.832042 | 0.67 | 2.5e-08 | Click! |
chr15_51990997_51992002 | Rad21 | 11 | 0.975241 | 0.43 | 1.2e-03 | Click! |
chr15_51983952_51984104 | Rad21 | 7482 | 0.178644 | -0.21 | 1.3e-01 | Click! |
chr15_51987356_51987507 | Rad21 | 4079 | 0.203360 | 0.12 | 3.7e-01 | Click! |
chr15_51990424_51990773 | Rad21 | 912 | 0.553921 | -0.10 | 4.7e-01 | Click! |
chr19_53648763_53649277 | Smc3 | 5662 | 0.186812 | 0.72 | 4.2e-10 | Click! |
chr19_53649452_53649603 | Smc3 | 6169 | 0.183650 | 0.50 | 1.1e-04 | Click! |
chr19_53600250_53600974 | Smc3 | 214 | 0.880436 | 0.37 | 5.3e-03 | Click! |
chr19_53602280_53602448 | Smc3 | 1966 | 0.250104 | -0.30 | 2.4e-02 | Click! |
chr19_53599854_53600236 | Smc3 | 353 | 0.655152 | 0.28 | 4.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_110050502_110051534 | 65.01 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chrX_75673394_75674325 | 45.19 |
Gm15065 |
predicted gene 15065 |
31550 |
0.13 |
chr9_56635860_56636539 | 44.82 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
571 |
0.77 |
chr7_64742016_64742211 | 39.01 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
1726 |
0.43 |
chr2_70126801_70127190 | 37.22 |
Myo3b |
myosin IIIB |
30697 |
0.2 |
chr18_36122085_36122561 | 34.25 |
4930471G03Rik |
RIKEN cDNA 4930471G03 gene |
16129 |
0.2 |
chr15_85708879_85709635 | 33.06 |
Mirlet7b |
microRNA let7b |
1938 |
0.23 |
chr8_45934560_45934989 | 30.90 |
Ccdc110 |
coiled-coil domain containing 110 |
132 |
0.93 |
chr14_12152048_12152237 | 30.87 |
Gm48603 |
predicted gene, 48603 |
442 |
0.81 |
chr4_63948156_63948307 | 30.13 |
8030451A03Rik |
RIKEN cDNA 8030451A03 gene |
31623 |
0.17 |
chr3_89215441_89216252 | 29.98 |
Thbs3 |
thrombospondin 3 |
613 |
0.38 |
chr6_83356602_83357036 | 29.92 |
Bola3 |
bolA-like 3 (E. coli) |
3506 |
0.15 |
chr19_33366744_33366922 | 29.76 |
Rnls |
renalase, FAD-dependent amine oxidase |
25432 |
0.18 |
chr14_48524282_48524433 | 29.46 |
Gm49519 |
predicted gene, 49519 |
237 |
0.89 |
chr12_29883340_29883518 | 29.12 |
Myt1l |
myelin transcription factor 1-like |
11685 |
0.26 |
chr11_32162265_32162460 | 29.04 |
Gm12109 |
predicted gene 12109 |
22643 |
0.12 |
chr18_35939531_35939985 | 28.84 |
Gm23882 |
predicted gene, 23882 |
13066 |
0.11 |
chr6_91286561_91286982 | 28.79 |
Fbln2 |
fibulin 2 |
20892 |
0.16 |
chr4_40014696_40014866 | 28.52 |
Gm26087 |
predicted gene, 26087 |
33223 |
0.16 |
chr2_12709166_12709591 | 28.49 |
Gm37565 |
predicted gene, 37565 |
11961 |
0.29 |
chr16_5145622_5145853 | 28.29 |
Sec14l5 |
SEC14-like lipid binding 5 |
1372 |
0.32 |
chr8_30923873_30924133 | 28.16 |
Gm45252 |
predicted gene 45252 |
79905 |
0.1 |
chr18_37218144_37218452 | 28.10 |
Gm10544 |
predicted gene 10544 |
39776 |
0.08 |
chr3_10685256_10685662 | 27.94 |
Gm37831 |
predicted gene, 37831 |
39143 |
0.17 |
chr8_4192812_4193553 | 27.94 |
Evi5l |
ecotropic viral integration site 5 like |
1890 |
0.19 |
chr12_113222098_113223172 | 27.86 |
Gm25622 |
predicted gene, 25622 |
8486 |
0.14 |
chr9_40616504_40616702 | 27.84 |
Gm48284 |
predicted gene, 48284 |
217 |
0.91 |
chr1_34583668_34584368 | 27.83 |
1700101I19Rik |
RIKEN cDNA 1700101I19 gene |
4307 |
0.1 |
chr7_46096261_46096440 | 27.24 |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
2076 |
0.17 |
chr7_79594952_79595267 | 26.93 |
Rhcg |
Rhesus blood group-associated C glycoprotein |
180 |
0.89 |
chr12_103324974_103325864 | 26.78 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
10165 |
0.11 |
chr13_64315565_64315761 | 26.77 |
Prxl2c |
peroxiredoxin like 2C |
2953 |
0.14 |
chr16_59403794_59403959 | 26.58 |
Gabrr3 |
gamma-aminobutyric acid (GABA) receptor, rho 3 |
3456 |
0.19 |
chr16_42165062_42165217 | 26.43 |
Gm49737 |
predicted gene, 49737 |
19778 |
0.18 |
chr6_55505206_55505360 | 26.18 |
Gm44352 |
predicted gene, 44352 |
28223 |
0.18 |
chr1_84697399_84697550 | 26.09 |
Dner |
delta/notch-like EGF repeat containing |
1253 |
0.35 |
chr13_83714747_83715651 | 26.03 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6182 |
0.14 |
chr3_35482419_35482596 | 25.97 |
Gm7733 |
predicted gene 7733 |
55293 |
0.12 |
chr12_29837553_29837737 | 25.89 |
Myt1l |
myelin transcription factor 1-like |
2565 |
0.4 |
chrX_93069865_93070046 | 25.73 |
Gm24973 |
predicted gene, 24973 |
80760 |
0.09 |
chr4_95008293_95008465 | 25.68 |
Gm12694 |
predicted gene 12694 |
29176 |
0.1 |
chr13_32411666_32411834 | 25.54 |
Gm11381 |
predicted gene 11381 |
28062 |
0.2 |
chr11_11131791_11131965 | 25.53 |
Gm23065 |
predicted gene, 23065 |
8636 |
0.24 |
chr5_21434297_21434450 | 25.38 |
Fam185a |
family with sequence similarity 185, member A |
356 |
0.87 |
chr8_95001110_95002377 | 25.12 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
862 |
0.47 |
chr3_89688754_89688942 | 25.08 |
Adar |
adenosine deaminase, RNA-specific |
26174 |
0.13 |
chr6_12260770_12260941 | 24.98 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
57474 |
0.15 |
chr13_83724808_83725277 | 24.94 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3064 |
0.17 |
chr2_106194434_106194642 | 24.81 |
Dcdc5 |
doublecortin domain containing 5 |
27519 |
0.21 |
chr8_10053567_10053726 | 24.78 |
Gm44788 |
predicted gene 44788 |
11408 |
0.17 |
chr13_110368616_110368889 | 24.76 |
Gapt |
Grb2-binding adaptor, transmembrane |
11553 |
0.22 |
chr7_108967100_108967309 | 24.54 |
Tub |
tubby bipartite transcription factor |
16547 |
0.13 |
chr18_69796023_69796378 | 24.48 |
Tcf4 |
transcription factor 4 |
113820 |
0.06 |
chr12_29676021_29676172 | 24.48 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
10349 |
0.29 |
chr3_28176650_28176892 | 24.37 |
Gm42196 |
predicted gene, 42196 |
218 |
0.95 |
chr6_64649984_64650163 | 24.36 |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
13115 |
0.27 |
chr13_109558377_109558555 | 24.34 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
22939 |
0.29 |
chr10_14391065_14391247 | 24.28 |
Gm48854 |
predicted gene, 48854 |
63745 |
0.1 |
chr2_70558238_70558404 | 24.20 |
Gad1 |
glutamate decarboxylase 1 |
3721 |
0.17 |
chr12_92303318_92303497 | 24.07 |
Gm6841 |
predicted gene 6841 |
84030 |
0.1 |
chr17_7306568_7306760 | 24.06 |
Gpr31a |
G protein-coupled receptor 31, D17Leh66a region |
9182 |
0.16 |
chr3_75136372_75136536 | 23.93 |
Zbbx |
zinc finger, B-box domain containing |
7249 |
0.3 |
chr8_102780946_102781228 | 23.86 |
Gm45258 |
predicted gene 45258 |
45 |
0.98 |
chr15_52505556_52505710 | 23.78 |
Gm23267 |
predicted gene, 23267 |
5977 |
0.2 |
chr10_20405548_20405747 | 23.75 |
Gm48537 |
predicted gene, 48537 |
40210 |
0.11 |
chr4_82614251_82614419 | 23.75 |
Gm11267 |
predicted gene 11267 |
27016 |
0.17 |
chr16_23898319_23898514 | 23.73 |
Sst |
somatostatin |
7458 |
0.19 |
chr10_46011889_46012235 | 23.64 |
Gpx4-ps2 |
glutathione peroxidase 4, pseudogene 2 |
136757 |
0.05 |
chr15_4056736_4056887 | 23.61 |
Oxct1 |
3-oxoacid CoA transferase 1 |
9552 |
0.16 |
chr14_7749491_7749764 | 23.56 |
Gm16741 |
predicted gene, 16741 |
318 |
0.87 |
chr9_57861999_57862190 | 23.54 |
Arid3b |
AT rich interactive domain 3B (BRIGHT-like) |
25301 |
0.14 |
chr11_8523634_8524133 | 23.54 |
Tns3 |
tensin 3 |
21468 |
0.27 |
chr3_31790445_31790596 | 23.46 |
Gm6558 |
predicted gene 6558 |
99935 |
0.08 |
chr6_61042953_61043250 | 23.43 |
Gm43892 |
predicted gene, 43892 |
1892 |
0.33 |
chr10_58812185_58812631 | 23.38 |
Gm9987 |
predicted gene 9987 |
734 |
0.49 |
chr16_31932750_31933099 | 23.37 |
Gm49731 |
predicted gene, 49731 |
723 |
0.36 |
chr12_65402116_65402289 | 23.26 |
Gm26015 |
predicted gene, 26015 |
3768 |
0.31 |
chr7_79547149_79547439 | 23.14 |
Gm35040 |
predicted gene, 35040 |
11251 |
0.09 |
chr16_59683550_59683733 | 23.05 |
Arl6 |
ADP-ribosylation factor-like 6 |
44250 |
0.14 |
chr8_55104196_55104391 | 22.73 |
Gm8734 |
predicted gene 8734 |
22578 |
0.16 |
chr8_113664648_113664870 | 22.73 |
Gm30052 |
predicted gene, 30052 |
11699 |
0.16 |
chr7_63322212_63322363 | 22.70 |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
109718 |
0.06 |
chr19_42316004_42316373 | 22.66 |
Crtac1 |
cartilage acidic protein 1 |
28234 |
0.12 |
chr7_40273530_40273694 | 22.64 |
4933404I11Rik |
RIKEN cDNA 4933404I11 gene |
10907 |
0.27 |
chr9_83727572_83727883 | 22.63 |
Gm2109 |
predicted gene 2109 |
36252 |
0.15 |
chr13_99837851_99838104 | 22.60 |
Cartpt |
CART prepropeptide |
62664 |
0.12 |
chr17_56487709_56487889 | 22.59 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
11316 |
0.14 |
chr7_79495990_79496302 | 22.59 |
Mir9-3hg |
Mir9-3 host gene |
3880 |
0.11 |
chr10_81289386_81289717 | 22.56 |
Tjp3 |
tight junction protein 3 |
1664 |
0.13 |
chr13_54766229_54766729 | 22.45 |
Sncb |
synuclein, beta |
13 |
0.96 |
chr15_72517103_72517267 | 22.44 |
Gm24390 |
predicted gene, 24390 |
26166 |
0.19 |
chr10_57743601_57744058 | 22.38 |
Pkib |
protein kinase inhibitor beta, cAMP dependent, testis specific |
15848 |
0.18 |
chr12_76081771_76082230 | 22.38 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
61 |
0.98 |
chr17_32634933_32635322 | 22.36 |
Cyp4f37 |
cytochrome P450, family 4, subfamily f, polypeptide 37 |
425 |
0.73 |
chr1_94079194_94079401 | 22.28 |
Pdcd1 |
programmed cell death 1 |
26744 |
0.18 |
chr1_82433427_82433623 | 22.27 |
Gm28940 |
predicted gene 28940 |
30779 |
0.15 |
chr8_27679243_27679432 | 22.24 |
Gm44493 |
predicted gene, 44493 |
63520 |
0.11 |
chr3_19904807_19905119 | 22.22 |
Gm37523 |
predicted gene, 37523 |
8833 |
0.17 |
chr2_180894820_180895150 | 22.21 |
Gm27032 |
predicted gene, 27032 |
880 |
0.31 |
chr15_31150915_31151098 | 22.18 |
Gm26416 |
predicted gene, 26416 |
43332 |
0.15 |
chr18_37217169_37217576 | 22.18 |
Gm10544 |
predicted gene 10544 |
38850 |
0.08 |
chr10_22579573_22579724 | 22.14 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
65363 |
0.1 |
chr6_117166930_117167143 | 22.13 |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
1499 |
0.38 |
chr4_53384812_53384965 | 22.13 |
Gm12496 |
predicted gene 12496 |
19142 |
0.2 |
chr2_129408564_129408715 | 22.10 |
Spcs2-ps |
signal peptidase complex subunit 2, pseudogene |
29243 |
0.11 |
chr5_90951610_90951767 | 22.06 |
Mthfd2l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
4914 |
0.17 |
chr19_20345008_20345207 | 22.02 |
1500015L24Rik |
RIKEN cDNA 1500015L24 gene |
20218 |
0.21 |
chr16_45196915_45197110 | 21.99 |
Gm6030 |
predicted gene 6030 |
8088 |
0.18 |
chr8_93591954_93592118 | 21.93 |
Gm45708 |
predicted gene 45708 |
16593 |
0.19 |
chr5_110493890_110494078 | 21.92 |
Gm32996 |
predicted gene, 32996 |
11783 |
0.13 |
chr13_81944176_81944347 | 21.92 |
F830210D05Rik |
RIKEN cDNA F830210D05 gene |
14574 |
0.26 |
chr2_105523334_105523796 | 21.91 |
Gm13890 |
predicted gene 13890 |
13917 |
0.19 |
chr9_25656183_25656339 | 21.91 |
Gm48330 |
predicted gene, 48330 |
29102 |
0.19 |
chr3_108401377_108402718 | 21.91 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
542 |
0.59 |
chr1_111242458_111242623 | 21.91 |
Gm19927 |
predicted gene, 19927 |
143378 |
0.05 |
chr6_81769276_81769434 | 21.87 |
Gm22530 |
predicted gene, 22530 |
37436 |
0.14 |
chr9_30480499_30480814 | 21.85 |
Gm47714 |
predicted gene, 47714 |
9303 |
0.2 |
chr14_53505540_53505691 | 21.81 |
Gm18711 |
predicted gene, 18711 |
39536 |
0.15 |
chr1_127500325_127500515 | 21.81 |
Tmem163 |
transmembrane protein 163 |
76 |
0.98 |
chr15_65703658_65703823 | 21.79 |
Gm23907 |
predicted gene, 23907 |
9191 |
0.22 |
chr11_66905944_66906160 | 21.72 |
Pirt |
phosphoinositide-interacting regulator of transient receptor potential channels |
5929 |
0.21 |
chr14_45602118_45602269 | 21.71 |
Ddhd1 |
DDHD domain containing 1 |
534 |
0.63 |
chr3_48846282_48846527 | 21.71 |
Gm37190 |
predicted gene, 37190 |
85455 |
0.1 |
chr7_57474263_57474422 | 21.68 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
35029 |
0.17 |
chr9_41191118_41191458 | 21.63 |
1700063D05Rik |
RIKEN cDNA 1700063D05 gene |
1158 |
0.41 |
chr5_52515323_52515508 | 21.59 |
Gm43685 |
predicted gene 43685 |
23416 |
0.13 |
chr1_11657743_11658030 | 21.53 |
Gm38069 |
predicted gene, 38069 |
46321 |
0.15 |
chr13_18868291_18868517 | 21.53 |
Vps41 |
VPS41 HOPS complex subunit |
23541 |
0.19 |
chr10_75151158_75151690 | 21.48 |
Bcr |
BCR activator of RhoGEF and GTPase |
8936 |
0.22 |
chr3_37204026_37204455 | 21.45 |
Gm12532 |
predicted gene 12532 |
21355 |
0.1 |
chr7_7278018_7278547 | 21.43 |
Gm45844 |
predicted gene 45844 |
7 |
0.49 |
chr5_91465223_91465374 | 21.41 |
Parm1 |
prostate androgen-regulated mucin-like protein 1 |
52317 |
0.14 |
chr9_26776197_26776451 | 21.40 |
Glb1l2 |
galactosidase, beta 1-like 2 |
7854 |
0.19 |
chr17_13043859_13044148 | 21.40 |
Gpr31b |
G protein-coupled receptor 31, D17Leh66b region |
8293 |
0.11 |
chr7_62209447_62209616 | 21.39 |
Gm9801 |
predicted gene 9801 |
52 |
0.98 |
chr15_66033986_66034182 | 21.38 |
Gm27153 |
predicted gene 27153 |
40468 |
0.15 |
chr2_135330337_135330507 | 21.35 |
Plcb1 |
phospholipase C, beta 1 |
81249 |
0.11 |
chr10_85221042_85221193 | 21.32 |
Cry1 |
cryptochrome 1 (photolyase-like) |
36053 |
0.13 |
chrX_13207639_13208350 | 21.31 |
Rpl3-ps1 |
ribosomal protein L3, pseudogene 1 |
5423 |
0.11 |
chr3_59120605_59120806 | 21.31 |
P2ry14 |
purinergic receptor P2Y, G-protein coupled, 14 |
9917 |
0.17 |
chr13_20311723_20311906 | 21.30 |
Elmo1 |
engulfment and cell motility 1 |
28897 |
0.2 |
chr11_29885255_29885429 | 21.30 |
Gm22588 |
predicted gene, 22588 |
35881 |
0.14 |
chr12_39510070_39510242 | 21.29 |
Gm47859 |
predicted gene, 47859 |
11239 |
0.2 |
chr1_34602467_34602645 | 21.21 |
Gm28418 |
predicted gene 28418 |
5163 |
0.1 |
chr10_62102119_62102476 | 21.20 |
Fam241b |
family with sequence similarity 241, member B |
8199 |
0.17 |
chr16_78637124_78637275 | 21.15 |
Gm24861 |
predicted gene, 24861 |
12452 |
0.2 |
chr4_151157023_151157226 | 21.13 |
Camta1 |
calmodulin binding transcription activator 1 |
17540 |
0.22 |
chr19_17124467_17124618 | 21.10 |
Prune2 |
prune homolog 2 |
1105 |
0.63 |
chr17_49935944_49936125 | 21.05 |
AC114824.1 |
potassium two pore domain channel subfamily K member (Kcnk) pseudogene |
8395 |
0.19 |
chr8_68361979_68362165 | 21.02 |
1700125H03Rik |
RIKEN cDNA 1700125H03 gene |
6362 |
0.22 |
chr5_73637805_73637979 | 20.99 |
Lrrc66 |
leucine rich repeat containing 66 |
5366 |
0.16 |
chr3_38884380_38884574 | 20.98 |
Fat4 |
FAT atypical cadherin 4 |
2463 |
0.32 |
chr17_63575711_63575893 | 20.96 |
Gm5497 |
predicted gene 5497 |
4899 |
0.24 |
chr17_42603446_42603756 | 20.96 |
Opn5 |
opsin 5 |
7794 |
0.28 |
chr1_162313677_162313870 | 20.93 |
Dnm3 |
dynamin 3 |
90 |
0.97 |
chr1_12864182_12864359 | 20.93 |
Sulf1 |
sulfatase 1 |
21479 |
0.22 |
chr8_63877483_63877678 | 20.83 |
Gm24580 |
predicted gene, 24580 |
616 |
0.78 |
chr2_124100990_124101211 | 20.77 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
11131 |
0.25 |
chr1_60860670_60860871 | 20.77 |
Gm38137 |
predicted gene, 38137 |
19568 |
0.12 |
chr2_85123906_85124180 | 20.75 |
Aplnr |
apelin receptor |
12182 |
0.12 |
chr1_132758634_132758970 | 20.73 |
Nfasc |
neurofascin |
17005 |
0.18 |
chrX_8948534_8948734 | 20.69 |
Gm5752 |
predicted gene 5752 |
6451 |
0.08 |
chr7_98120340_98120723 | 20.68 |
Myo7a |
myosin VIIA |
1007 |
0.52 |
chr5_43634802_43634990 | 20.67 |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
27450 |
0.13 |
chr5_27075112_27075294 | 20.64 |
Dpp6 |
dipeptidylpeptidase 6 |
25810 |
0.22 |
chr12_31374654_31374924 | 20.62 |
Slc26a3 |
solute carrier family 26, member 3 |
16082 |
0.14 |
chr10_62105295_62105446 | 20.61 |
Fam241b |
family with sequence similarity 241, member B |
5126 |
0.18 |
chr10_14332669_14332906 | 20.61 |
Gm48854 |
predicted gene, 48854 |
5376 |
0.19 |
chr6_82917848_82918001 | 20.58 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
338 |
0.78 |
chr15_64687315_64687492 | 20.55 |
Gm30691 |
predicted gene, 30691 |
53895 |
0.16 |
chr7_139877520_139877671 | 20.55 |
Gm4974 |
predicted gene 4974 |
10756 |
0.12 |
chr7_30216721_30217157 | 20.52 |
Gm44600 |
predicted gene 44600 |
4201 |
0.08 |
chr16_23898938_23899119 | 20.52 |
Sst |
somatostatin |
8070 |
0.18 |
chr5_113366052_113366203 | 20.51 |
Aym1 |
activator of yeast meiotic promoters 1 |
8833 |
0.15 |
chr2_146414780_146414972 | 20.50 |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
2000 |
0.44 |
chr8_34816206_34816423 | 20.49 |
Dusp4 |
dual specificity phosphatase 4 |
9017 |
0.22 |
chr2_91328381_91328716 | 20.49 |
Gm13787 |
predicted gene 13787 |
15641 |
0.15 |
chr3_34232049_34232222 | 20.48 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
35271 |
0.16 |
chr9_39509158_39509309 | 20.47 |
Olfr957 |
olfactory receptor 957 |
2485 |
0.15 |
chr3_38887381_38887941 | 20.47 |
C230034O21Rik |
RIKEN cDNA C230034O21 gene |
598 |
0.52 |
chr13_37312653_37312834 | 20.46 |
Gm47711 |
predicted gene, 47711 |
13723 |
0.16 |
chr6_119220389_119220553 | 20.44 |
Dcp1b |
decapping mRNA 1B |
2927 |
0.26 |
chr12_51188322_51188499 | 20.41 |
Gm7172 |
predicted gene 7172 |
53708 |
0.14 |
chr12_41487074_41487242 | 20.40 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
727 |
0.73 |
chr8_93932970_93933218 | 20.40 |
Gm24159 |
predicted gene, 24159 |
842 |
0.58 |
chr11_12579318_12579469 | 20.40 |
Gm22156 |
predicted gene, 22156 |
97540 |
0.08 |
chr17_53387991_53388142 | 20.39 |
Gm9214 |
predicted gene 9214 |
28139 |
0.14 |
chr1_81316744_81316925 | 20.36 |
Gm37210 |
predicted gene, 37210 |
205507 |
0.02 |
chr7_89126595_89126827 | 20.32 |
Tmem135 |
transmembrane protein 135 |
18786 |
0.24 |
chr4_22017977_22018176 | 20.32 |
Gm11885 |
predicted gene 11885 |
9887 |
0.24 |
chr10_27133214_27133408 | 20.28 |
Lama2 |
laminin, alpha 2 |
76666 |
0.1 |
chr14_123661112_123661334 | 20.28 |
Itgbl1 |
integrin, beta-like 1 |
201 |
0.95 |
chr14_6756349_6757421 | 20.27 |
Gm3636 |
predicted gene 3636 |
14553 |
0.14 |
chr4_31366167_31366509 | 20.24 |
Gm11922 |
predicted gene 11922 |
14134 |
0.31 |
chr17_7420321_7420535 | 20.21 |
Gm6553 |
predicted gene 6553 |
9814 |
0.17 |
chr18_43393020_43393658 | 20.19 |
Dpysl3 |
dihydropyrimidinase-like 3 |
38 |
0.98 |
chr9_106112873_106113024 | 20.19 |
Gm9451 |
predicted gene 9451 |
8951 |
0.1 |
chr1_65010262_65010447 | 20.19 |
Akr1cl |
aldo-keto reductase family 1, member C-like |
6189 |
0.11 |
chr9_97068783_97069009 | 20.17 |
Gm19325 |
predicted gene, 19325 |
1589 |
0.29 |
chr17_58870871_58871022 | 20.15 |
Pdzph1 |
PDZ and pleckstrin homology domains 1 |
13187 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.1 | 36.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
10.4 | 31.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
9.9 | 29.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
9.6 | 9.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
9.5 | 38.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
8.4 | 25.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
8.1 | 24.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
7.9 | 23.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
7.6 | 22.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
7.4 | 22.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
7.4 | 14.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
7.3 | 21.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
7.2 | 21.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
7.0 | 14.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
6.8 | 20.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
6.4 | 19.1 | GO:0030070 | insulin processing(GO:0030070) |
6.3 | 31.5 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
6.2 | 12.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
6.1 | 24.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
5.9 | 23.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
5.9 | 17.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
5.7 | 17.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
5.6 | 16.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
5.5 | 16.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
5.3 | 26.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
5.2 | 15.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
5.1 | 20.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
4.9 | 14.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
4.8 | 14.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
4.7 | 9.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
4.6 | 37.1 | GO:0015824 | proline transport(GO:0015824) |
4.6 | 32.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
4.5 | 18.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
4.4 | 13.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
4.4 | 13.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
4.4 | 8.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
4.3 | 13.0 | GO:0097503 | sialylation(GO:0097503) |
4.3 | 13.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
4.3 | 13.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
4.3 | 17.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.3 | 38.8 | GO:0050957 | equilibrioception(GO:0050957) |
4.3 | 25.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
4.3 | 8.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
4.2 | 12.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
4.2 | 16.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
4.2 | 8.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
4.1 | 4.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
4.1 | 12.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
4.0 | 15.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
4.0 | 15.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.9 | 3.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
3.9 | 7.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
3.8 | 15.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
3.8 | 15.2 | GO:0014028 | notochord formation(GO:0014028) |
3.7 | 15.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
3.7 | 11.2 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
3.7 | 14.8 | GO:0046959 | habituation(GO:0046959) |
3.7 | 22.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
3.7 | 11.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
3.7 | 22.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
3.7 | 7.3 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
3.6 | 7.2 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
3.6 | 21.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
3.6 | 25.2 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
3.6 | 14.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
3.5 | 3.5 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
3.5 | 14.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
3.5 | 17.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.5 | 3.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
3.5 | 10.5 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
3.4 | 6.9 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
3.4 | 13.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.4 | 13.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
3.4 | 10.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
3.4 | 10.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
3.3 | 13.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.3 | 13.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
3.3 | 16.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
3.3 | 36.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
3.3 | 9.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
3.2 | 9.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
3.2 | 6.4 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
3.2 | 9.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
3.2 | 9.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
3.1 | 9.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
3.1 | 15.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
3.1 | 21.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
3.1 | 9.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
3.1 | 9.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
3.1 | 6.2 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.1 | 9.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
3.0 | 3.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
3.0 | 21.3 | GO:0030432 | peristalsis(GO:0030432) |
3.0 | 3.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.0 | 12.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
3.0 | 32.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
3.0 | 5.9 | GO:0003032 | detection of oxygen(GO:0003032) |
2.9 | 8.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.9 | 8.8 | GO:0032252 | secretory granule localization(GO:0032252) |
2.9 | 37.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.9 | 8.7 | GO:1903232 | melanosome assembly(GO:1903232) |
2.9 | 26.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.9 | 8.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.9 | 14.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
2.9 | 5.7 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
2.9 | 11.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
2.8 | 2.8 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
2.8 | 17.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
2.8 | 11.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
2.8 | 2.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
2.8 | 2.8 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
2.7 | 16.4 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
2.7 | 16.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.7 | 5.4 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.7 | 10.8 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
2.7 | 21.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
2.7 | 8.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
2.7 | 5.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
2.7 | 8.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.6 | 13.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.6 | 7.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.6 | 46.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
2.5 | 7.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.5 | 7.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.5 | 5.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.5 | 5.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
2.5 | 17.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.5 | 9.9 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.5 | 7.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.5 | 14.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.5 | 22.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
2.4 | 7.3 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
2.4 | 19.6 | GO:0070253 | somatostatin secretion(GO:0070253) |
2.4 | 4.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.4 | 4.9 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
2.4 | 7.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
2.4 | 4.8 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
2.4 | 2.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.4 | 7.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.4 | 2.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
2.4 | 4.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
2.3 | 9.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.3 | 2.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.3 | 7.0 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
2.3 | 9.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
2.3 | 6.9 | GO:0033058 | directional locomotion(GO:0033058) |
2.3 | 4.6 | GO:0015888 | thiamine transport(GO:0015888) |
2.3 | 6.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
2.3 | 6.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
2.3 | 2.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
2.3 | 4.5 | GO:0046958 | nonassociative learning(GO:0046958) |
2.3 | 11.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.2 | 9.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
2.2 | 2.2 | GO:0060166 | olfactory pit development(GO:0060166) |
2.2 | 11.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.2 | 4.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
2.2 | 2.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
2.2 | 11.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.2 | 4.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.2 | 4.4 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
2.2 | 6.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.2 | 6.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
2.2 | 2.2 | GO:0030035 | microspike assembly(GO:0030035) |
2.2 | 11.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
2.2 | 2.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.2 | 8.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
2.2 | 6.6 | GO:0019042 | viral latency(GO:0019042) |
2.2 | 6.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
2.2 | 2.2 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
2.2 | 6.5 | GO:0043366 | beta selection(GO:0043366) |
2.2 | 15.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
2.2 | 2.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
2.2 | 2.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.2 | 10.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
2.2 | 8.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
2.1 | 10.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
2.1 | 8.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
2.1 | 12.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
2.1 | 6.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.1 | 23.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.1 | 2.1 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
2.1 | 6.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.1 | 4.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
2.1 | 35.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
2.1 | 4.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
2.1 | 4.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
2.1 | 16.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
2.1 | 8.3 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
2.1 | 4.1 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
2.1 | 6.2 | GO:0007525 | somatic muscle development(GO:0007525) |
2.1 | 16.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.1 | 2.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
2.1 | 6.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
2.1 | 2.1 | GO:0060459 | left lung development(GO:0060459) |
2.1 | 2.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
2.0 | 4.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.0 | 2.0 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
2.0 | 10.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
2.0 | 6.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.0 | 4.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
2.0 | 10.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
2.0 | 2.0 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
2.0 | 12.2 | GO:0015884 | folic acid transport(GO:0015884) |
2.0 | 6.1 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
2.0 | 6.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.0 | 46.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
2.0 | 6.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.0 | 16.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
2.0 | 23.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
2.0 | 6.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
2.0 | 2.0 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
2.0 | 2.0 | GO:1903416 | response to glycoside(GO:1903416) |
2.0 | 11.9 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
2.0 | 2.0 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
2.0 | 9.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.0 | 2.0 | GO:0097061 | dendritic spine organization(GO:0097061) dendritic spine maintenance(GO:0097062) |
1.9 | 1.9 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.9 | 1.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.9 | 17.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.9 | 3.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.9 | 7.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
1.9 | 5.8 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
1.9 | 9.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.9 | 9.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.9 | 1.9 | GO:0008078 | mesodermal cell migration(GO:0008078) |
1.9 | 3.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.9 | 17.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.9 | 15.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.9 | 1.9 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
1.9 | 1.9 | GO:0035973 | aggrephagy(GO:0035973) |
1.9 | 11.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.9 | 3.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.9 | 1.9 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.9 | 5.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.8 | 18.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.8 | 20.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.8 | 12.9 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.8 | 1.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.8 | 1.8 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.8 | 9.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
1.8 | 7.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.8 | 5.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.8 | 1.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
1.8 | 19.9 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
1.8 | 5.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.8 | 10.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.8 | 7.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.8 | 10.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.8 | 9.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.8 | 14.4 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
1.8 | 9.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.8 | 3.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.8 | 5.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.8 | 7.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.8 | 10.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.8 | 8.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.8 | 5.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.8 | 15.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.8 | 52.7 | GO:0019228 | neuronal action potential(GO:0019228) |
1.8 | 7.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.8 | 19.3 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
1.7 | 5.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.7 | 5.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.7 | 3.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.7 | 6.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.7 | 3.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.7 | 3.4 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
1.7 | 5.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.7 | 5.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.7 | 3.4 | GO:0006562 | proline catabolic process(GO:0006562) |
1.7 | 1.7 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
1.7 | 8.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.7 | 5.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.7 | 6.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.7 | 3.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.7 | 6.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.7 | 1.7 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
1.7 | 3.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.7 | 1.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
1.7 | 3.3 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
1.6 | 4.9 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.6 | 3.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.6 | 4.9 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.6 | 16.4 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
1.6 | 14.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.6 | 3.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
1.6 | 1.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.6 | 6.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.6 | 3.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.6 | 4.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.6 | 8.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.6 | 4.8 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.6 | 9.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.6 | 4.8 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.6 | 11.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.6 | 6.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.6 | 3.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.6 | 26.9 | GO:0010107 | potassium ion import(GO:0010107) |
1.6 | 4.7 | GO:0061055 | myotome development(GO:0061055) |
1.6 | 1.6 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
1.6 | 6.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.6 | 43.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.6 | 3.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.6 | 3.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.6 | 26.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.5 | 1.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.5 | 6.2 | GO:0046909 | intermembrane transport(GO:0046909) |
1.5 | 1.5 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.5 | 6.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.5 | 30.7 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
1.5 | 6.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.5 | 1.5 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.5 | 3.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.5 | 7.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.5 | 4.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.5 | 1.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.5 | 9.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
1.5 | 3.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.5 | 6.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.5 | 4.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.5 | 4.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.5 | 3.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.5 | 4.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.5 | 22.3 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.5 | 1.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.5 | 1.5 | GO:0090135 | actin filament branching(GO:0090135) |
1.5 | 3.0 | GO:0019086 | late viral transcription(GO:0019086) |
1.5 | 7.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.5 | 1.5 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.5 | 4.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.5 | 7.4 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
1.5 | 11.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.5 | 22.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.5 | 1.5 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.5 | 13.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.5 | 4.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.5 | 4.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.5 | 4.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.5 | 4.4 | GO:0031296 | B cell costimulation(GO:0031296) |
1.4 | 10.1 | GO:0060290 | transdifferentiation(GO:0060290) |
1.4 | 28.9 | GO:0042417 | dopamine metabolic process(GO:0042417) |
1.4 | 1.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.4 | 1.4 | GO:0048880 | sensory system development(GO:0048880) |
1.4 | 4.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.4 | 5.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.4 | 8.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 2.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.4 | 5.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.4 | 11.4 | GO:0008038 | neuron recognition(GO:0008038) |
1.4 | 7.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.4 | 9.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.4 | 5.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.4 | 1.4 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
1.4 | 1.4 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.4 | 5.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.4 | 2.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.4 | 4.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.4 | 2.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.4 | 1.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.4 | 18.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
1.4 | 6.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.4 | 1.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.4 | 2.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.4 | 4.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 1.4 | GO:0061743 | motor learning(GO:0061743) |
1.4 | 2.7 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 6.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
1.4 | 8.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.4 | 1.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.4 | 4.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.4 | 6.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.4 | 1.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
1.4 | 1.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.3 | 6.7 | GO:0070842 | aggresome assembly(GO:0070842) |
1.3 | 14.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
1.3 | 9.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.3 | 8.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.3 | 8.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.3 | 4.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.3 | 5.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.3 | 14.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
1.3 | 4.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.3 | 2.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.3 | 5.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.3 | 5.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.3 | 4.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.3 | 29.0 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.3 | 10.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.3 | 3.9 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.3 | 3.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.3 | 2.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.3 | 3.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 2.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.3 | 5.2 | GO:0015871 | choline transport(GO:0015871) |
1.3 | 7.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.3 | 1.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
1.3 | 9.0 | GO:0006108 | malate metabolic process(GO:0006108) |
1.3 | 3.8 | GO:0060005 | vestibular reflex(GO:0060005) |
1.3 | 2.6 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.3 | 6.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.3 | 1.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.3 | 11.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.3 | 1.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.3 | 3.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.3 | 2.5 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.3 | 2.5 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
1.3 | 1.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.3 | 3.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.3 | 1.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.3 | 6.3 | GO:0051875 | pigment granule localization(GO:0051875) |
1.3 | 3.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.2 | 2.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.2 | 12.4 | GO:0006828 | manganese ion transport(GO:0006828) |
1.2 | 13.6 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
1.2 | 6.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.2 | 19.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.2 | 1.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.2 | 16.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
1.2 | 8.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.2 | 9.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.2 | 13.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.2 | 8.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.2 | 3.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.2 | 10.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.2 | 3.6 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.2 | 8.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.2 | 4.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.2 | 6.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.2 | 3.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.2 | 6.0 | GO:0042637 | catagen(GO:0042637) |
1.2 | 1.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.2 | 1.2 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
1.2 | 2.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.2 | 1.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.2 | 4.8 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
1.2 | 8.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.2 | 3.6 | GO:0001696 | gastric acid secretion(GO:0001696) |
1.2 | 2.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.2 | 3.5 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
1.2 | 3.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.2 | 5.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.2 | 4.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.2 | 3.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.2 | 3.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.2 | 3.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.2 | 5.8 | GO:0016322 | neuron remodeling(GO:0016322) |
1.2 | 2.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.2 | 4.6 | GO:0032341 | aldosterone metabolic process(GO:0032341) |
1.2 | 5.8 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
1.2 | 15.0 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.2 | 1.2 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.2 | 6.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.2 | 5.8 | GO:0080009 | mRNA methylation(GO:0080009) |
1.2 | 1.2 | GO:0098739 | import across plasma membrane(GO:0098739) |
1.1 | 5.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.1 | 4.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.1 | 8.0 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.1 | 2.3 | GO:0072197 | renal vesicle induction(GO:0072034) ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
1.1 | 5.7 | GO:0051775 | response to redox state(GO:0051775) |
1.1 | 2.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.1 | 2.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.1 | 1.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
1.1 | 2.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.1 | 3.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.1 | 1.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
1.1 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.1 | 13.5 | GO:0060384 | innervation(GO:0060384) |
1.1 | 3.4 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
1.1 | 2.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.1 | 4.5 | GO:0048664 | neuron fate determination(GO:0048664) |
1.1 | 12.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.1 | 6.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.1 | 1.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
1.1 | 8.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
1.1 | 7.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.1 | 7.8 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.1 | 12.2 | GO:0001964 | startle response(GO:0001964) |
1.1 | 3.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.1 | 4.4 | GO:0030091 | protein repair(GO:0030091) |
1.1 | 11.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.1 | 4.4 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
1.1 | 1.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.1 | 4.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.1 | 5.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.1 | 5.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.1 | 11.0 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.1 | 2.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.1 | 2.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
1.1 | 18.7 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
1.1 | 3.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.1 | 2.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.1 | 21.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.1 | 3.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.1 | 6.5 | GO:0032060 | bleb assembly(GO:0032060) |
1.1 | 2.1 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
1.1 | 2.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.1 | 45.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 9.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.1 | 7.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
1.1 | 19.0 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
1.1 | 4.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.1 | 4.2 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.0 | 1.0 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
1.0 | 1.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.0 | 11.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.0 | 2.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.0 | 1.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.0 | 6.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.0 | 3.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 1.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
1.0 | 1.0 | GO:1902896 | terminal web assembly(GO:1902896) |
1.0 | 3.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
1.0 | 1.0 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.0 | 3.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.0 | 2.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
1.0 | 3.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
1.0 | 5.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.0 | 11.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
1.0 | 10.3 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
1.0 | 1.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
1.0 | 2.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.0 | 7.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.0 | 4.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.0 | 7.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.0 | 1.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.0 | 30.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.0 | 3.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.0 | 3.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 4.0 | GO:0009597 | detection of virus(GO:0009597) |
1.0 | 2.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.0 | 4.0 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.0 | 1.0 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
1.0 | 2.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 5.0 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
1.0 | 2.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.0 | 1.0 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
1.0 | 4.9 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.0 | 1.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.0 | 3.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.0 | 4.9 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.0 | 2.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.0 | 3.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
1.0 | 3.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.0 | 2.0 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
1.0 | 3.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.0 | 3.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 1.9 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.0 | 1.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.0 | 2.9 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.0 | 1.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.0 | 3.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.0 | 1.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 3.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.0 | 2.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.0 | 2.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.0 | 1.0 | GO:0032637 | interleukin-8 production(GO:0032637) |
1.0 | 1.0 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.9 | 11.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.9 | 4.7 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.9 | 1.9 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.9 | 9.3 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.9 | 5.6 | GO:0007379 | segment specification(GO:0007379) |
0.9 | 5.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.9 | 0.9 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.9 | 7.4 | GO:0036065 | fucosylation(GO:0036065) |
0.9 | 1.8 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.9 | 0.9 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.9 | 1.8 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.9 | 4.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.9 | 0.9 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.9 | 5.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 1.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.9 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.9 | 6.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.9 | 0.9 | GO:0045472 | response to ether(GO:0045472) |
0.9 | 0.9 | GO:0048382 | mesendoderm development(GO:0048382) |
0.9 | 0.9 | GO:1901660 | calcium ion export(GO:1901660) |
0.9 | 0.9 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.9 | 1.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.9 | 1.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.9 | 1.8 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 2.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.9 | 1.8 | GO:0009629 | response to gravity(GO:0009629) |
0.9 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.9 | 2.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.9 | 1.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.9 | 5.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.9 | 0.9 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.9 | 0.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.9 | 1.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.9 | 0.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.9 | 2.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.9 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.9 | 8.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.9 | 3.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.9 | 5.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.9 | 1.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.9 | 1.8 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.9 | 0.9 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.9 | 2.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.9 | 0.9 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.9 | 0.9 | GO:0042161 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.9 | 1.7 | GO:0009651 | response to salt stress(GO:0009651) |
0.9 | 4.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.9 | 1.7 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.9 | 3.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.9 | 3.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.9 | 3.4 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.9 | 1.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.9 | 1.7 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.8 | 4.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.8 | 4.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 3.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.8 | 0.8 | GO:0048859 | negative regulation of epidermal cell differentiation(GO:0045605) formation of anatomical boundary(GO:0048859) |
0.8 | 1.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.8 | 3.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.8 | 0.8 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.8 | 5.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.8 | 5.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.8 | 2.5 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.8 | 2.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.8 | 3.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.8 | 1.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.8 | 0.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.8 | 1.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 2.5 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.8 | 3.3 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
0.8 | 2.5 | GO:0060618 | nipple development(GO:0060618) |
0.8 | 3.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.8 | 1.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 6.5 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
0.8 | 1.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.8 | 1.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.8 | 7.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.8 | 1.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.8 | 2.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.8 | 1.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.8 | 7.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.8 | 2.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.8 | 4.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.8 | 4.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.8 | 1.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 9.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.8 | 2.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.8 | 2.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 2.4 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.8 | 1.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.8 | 1.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.8 | 3.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.8 | 0.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.8 | 4.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.8 | 3.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.8 | 29.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.8 | 4.7 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.8 | 1.6 | GO:0007320 | insemination(GO:0007320) |
0.8 | 2.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.8 | 2.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 6.3 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.8 | 1.6 | GO:0007625 | grooming behavior(GO:0007625) |
0.8 | 2.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.8 | 6.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.8 | 1.6 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.8 | 1.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.8 | 5.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.8 | 0.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.8 | 2.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.8 | 3.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.8 | 0.8 | GO:0034205 | beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) |
0.8 | 3.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.8 | 3.8 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.8 | 1.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.8 | 3.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.8 | 1.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.8 | 3.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.8 | 1.5 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.8 | 6.8 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.7 | 21.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.7 | 8.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.7 | 3.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.7 | 1.5 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 5.9 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.7 | 0.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.7 | 4.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 2.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.7 | 6.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.7 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.7 | 2.2 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.7 | 2.2 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.7 | 1.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.7 | 2.9 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.7 | 3.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 0.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.7 | 1.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.7 | 2.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.7 | 36.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.7 | 2.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.7 | 15.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.7 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 2.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.7 | 2.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.7 | 2.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 0.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.7 | 1.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.7 | 0.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.7 | 2.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 2.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.7 | 4.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.7 | 2.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.7 | 0.7 | GO:1902074 | response to salt(GO:1902074) |
0.7 | 2.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.7 | 1.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 0.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.7 | 4.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.7 | 1.4 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.7 | 2.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 1.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.7 | 0.7 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.7 | 2.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.7 | 0.7 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.7 | 8.3 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.7 | 2.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.7 | 3.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.7 | 6.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 1.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 11.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.7 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 4.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of cell cycle checkpoint(GO:1901978) |
0.7 | 1.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.7 | 2.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.7 | 2.7 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.7 | 3.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 0.7 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.7 | 1.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 0.7 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.7 | 2.0 | GO:0021794 | thalamus development(GO:0021794) |
0.7 | 1.4 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.7 | 0.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.7 | 1.4 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.7 | 18.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.7 | 2.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.7 | 4.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 1.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.7 | 7.3 | GO:0051180 | vitamin transport(GO:0051180) |
0.7 | 6.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 2.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 7.9 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.7 | 1.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 7.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.6 | 1.9 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.6 | 0.6 | GO:0090110 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
0.6 | 1.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.6 | 3.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.6 | 0.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.6 | 0.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.6 | 1.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.6 | 3.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.6 | 1.9 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.6 | 5.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.6 | 0.6 | GO:0043383 | negative T cell selection(GO:0043383) |
0.6 | 0.6 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.6 | 1.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.6 | 0.6 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.6 | 6.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.6 | 1.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.6 | 3.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 19.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.6 | 2.5 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 0.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 1.9 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.6 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.6 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 4.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 14.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.6 | 1.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.6 | 1.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 3.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 1.2 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.6 | 4.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.6 | 1.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.6 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.6 | 4.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 2.4 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 1.2 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.6 | 3.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.6 | 1.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 4.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 1.8 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.6 | 0.6 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.6 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.6 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 1.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.6 | 3.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.6 | 1.2 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.6 | 3.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.6 | 0.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.6 | 3.0 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.6 | 3.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.6 | 3.0 | GO:0071404 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.6 | 6.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.6 | 1.8 | GO:0021854 | hypothalamus development(GO:0021854) |
0.6 | 0.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.6 | 2.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 2.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.6 | 5.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.6 | 1.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 1.7 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.6 | 1.7 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.6 | 1.7 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.6 | 1.7 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.6 | 7.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.6 | 1.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 2.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.6 | 1.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.6 | 2.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.6 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 2.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.6 | 3.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.6 | 1.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.6 | 2.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.6 | 2.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.6 | 0.6 | GO:0015744 | succinate transport(GO:0015744) |
0.6 | 2.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.6 | 2.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.6 | 1.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 3.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 2.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 1.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.5 | 0.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.5 | 2.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.5 | 2.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 2.2 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.5 | 1.6 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.5 | 2.7 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.5 | 3.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.5 | 1.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 1.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.5 | 0.5 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.5 | 7.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 1.6 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.5 | 3.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 2.7 | GO:0098534 | centriole assembly(GO:0098534) |
0.5 | 4.8 | GO:0030431 | sleep(GO:0030431) |
0.5 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 2.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 0.5 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.5 | 2.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 2.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 28.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.5 | 3.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.5 | 1.6 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 3.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 14.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.5 | 0.5 | GO:0060157 | urinary bladder development(GO:0060157) |
0.5 | 5.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.5 | 1.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 2.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 4.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 2.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 2.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.5 | 0.5 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.5 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.5 | 3.6 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.5 | 1.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 2.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 1.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.5 | 3.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 2.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.5 | 3.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 2.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.5 | 1.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.5 | 2.5 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.5 | 1.0 | GO:0042048 | olfactory behavior(GO:0042048) |
0.5 | 1.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 5.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.5 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 4.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 1.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 1.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 2.5 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.5 | 6.5 | GO:0090102 | cochlea development(GO:0090102) |
0.5 | 0.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.5 | 1.5 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 2.0 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.5 | 1.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 2.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.5 | 5.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.5 | 4.5 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.5 | 7.9 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.5 | 31.1 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.5 | 1.5 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 1.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 7.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.5 | 0.5 | GO:0046514 | glycosphingolipid catabolic process(GO:0046479) ceramide catabolic process(GO:0046514) |
0.5 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.5 | 0.5 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 3.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.5 | 1.5 | GO:1903333 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.5 | 18.5 | GO:0007612 | learning(GO:0007612) |
0.5 | 1.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.5 | 2.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 1.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.5 | 0.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 1.4 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.5 | 1.9 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 5.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.5 | 1.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 0.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 1.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.5 | 1.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 3.8 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.5 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.5 | 3.3 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.5 | 0.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 4.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.5 | 0.5 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
0.5 | 1.9 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 1.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 5.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.5 | 0.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.5 | 1.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.5 | 1.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 2.7 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.5 | 5.5 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 1.8 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.5 | 1.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 1.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.5 | 1.8 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.4 | 0.9 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.4 | 1.3 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.4 | 2.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.4 | 0.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 2.7 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 2.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.3 | GO:0060065 | uterus development(GO:0060065) |
0.4 | 1.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 1.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 3.1 | GO:0003341 | cilium movement(GO:0003341) |
0.4 | 3.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.4 | 1.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.4 | 4.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.4 | 1.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.4 | 5.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.4 | 1.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.4 | 3.9 | GO:0030539 | male genitalia development(GO:0030539) |
0.4 | 1.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.4 | 1.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 1.3 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.4 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.4 | 0.9 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.4 | 0.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.4 | 0.4 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.4 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 3.0 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.4 | 1.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 11.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.4 | 1.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 0.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.4 | 0.8 | GO:0060073 | micturition(GO:0060073) |
0.4 | 3.8 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 0.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.4 | 1.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 1.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 1.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.4 | 1.2 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.4 | 4.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 2.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 2.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.2 | GO:0033574 | response to testosterone(GO:0033574) |
0.4 | 0.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.4 | 1.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 2.0 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.4 | 1.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.4 | 2.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 5.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.4 | 0.8 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 1.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 0.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 1.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 2.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 0.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 1.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.4 | 2.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.4 | 1.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.4 | 4.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.4 | 1.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.4 | 0.4 | GO:0086002 | cardiac muscle cell action potential involved in contraction(GO:0086002) |
0.4 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.4 | 2.8 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.4 | 1.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.4 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 1.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.4 | 2.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 4.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.4 | 0.4 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.4 | 3.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.4 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 7.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.4 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 0.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 2.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.4 | 2.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 0.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.4 | 2.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.4 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 1.9 | GO:0048806 | genitalia development(GO:0048806) |
0.4 | 3.8 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.4 | 0.4 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.4 | 3.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.4 | 2.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 6.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.4 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 2.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 0.4 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.4 | 0.4 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.4 | 1.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 1.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 1.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 24.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.4 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.4 | 2.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.4 | 0.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 1.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 0.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 2.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 2.9 | GO:0035094 | response to nicotine(GO:0035094) |
0.4 | 0.4 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.4 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 0.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 2.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.4 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.4 | 1.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.4 | 0.7 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 0.7 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 0.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 0.4 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 1.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.3 | 2.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.3 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 1.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 5.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.3 | 0.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.3 | 0.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 1.7 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.3 | 3.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 0.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 2.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 0.7 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.3 | 1.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.3 | 0.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.7 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 1.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 0.7 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.3 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 8.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 4.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 1.6 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.3 | 2.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.3 | 0.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 6.8 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.3 | 4.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 0.3 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.3 | 0.3 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.3 | 1.9 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 1.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 1.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 0.3 | GO:2000136 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.3 | 0.3 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.3 | 0.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 0.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 0.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 4.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 1.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.3 | 1.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.3 | 0.3 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.3 | 8.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.3 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 2.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 2.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 0.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 8.6 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.3 | 2.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.6 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.3 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.3 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.3 | 2.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 1.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.3 | 0.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 0.9 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.4 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.3 | 0.3 | GO:0097468 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) |
0.3 | 0.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 2.8 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 0.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.8 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 1.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 3.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.3 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.3 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 2.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 2.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 1.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.3 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.3 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 1.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 1.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 0.8 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 3.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.8 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 6.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 1.3 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.3 | 1.1 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.3 | 2.1 | GO:0055021 | regulation of cardiac muscle tissue growth(GO:0055021) regulation of cardiac muscle cell proliferation(GO:0060043) |
0.3 | 1.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 0.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 9.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.3 | 1.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 8.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.3 | 1.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.3 | 0.5 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 0.5 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 4.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 3.0 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 2.2 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.2 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.5 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 3.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 1.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.2 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.2 | GO:0060420 | regulation of heart growth(GO:0060420) |
0.2 | 0.2 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.2 | 3.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 9.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 1.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 6.7 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.7 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 1.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 1.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.5 | GO:0071638 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 1.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 2.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 1.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 2.3 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.2 | 0.5 | GO:0044241 | lipid digestion(GO:0044241) |
0.2 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 5.3 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 2.7 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 3.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.2 | 1.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 7.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.9 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.2 | 0.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.2 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.2 | 1.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.9 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.2 | 0.2 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.2 | 2.2 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.2 | 0.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 8.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 2.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.2 | GO:0086065 | cell communication involved in cardiac conduction(GO:0086065) |
0.2 | 0.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.4 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
0.2 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.6 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.2 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.4 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.2 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 1.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 0.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 2.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 2.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 3.4 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 1.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 1.4 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 1.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 2.7 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.2 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 1.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 2.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 6.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.2 | 0.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.4 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.2 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.2 | 3.4 | GO:0006818 | hydrogen transport(GO:0006818) |
0.2 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 19.6 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.2 | 0.5 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 6.9 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.2 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 1.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.5 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 4.4 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.2 | 1.8 | GO:0009268 | response to pH(GO:0009268) |
0.2 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.2 | 0.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 3.6 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.2 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 0.5 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.2 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.2 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.3 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.5 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.4 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 2.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 1.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 1.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 1.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.3 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.7 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 2.0 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.1 | 0.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 11.3 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.1 | 0.1 | GO:0061337 | cardiac conduction(GO:0061337) |
0.1 | 0.1 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.1 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.1 | 1.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.2 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.2 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 0.2 | GO:0034397 | telomere localization(GO:0034397) |
0.1 | 0.2 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.1 | 1.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 4.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.8 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.2 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.3 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0071599 | otic vesicle development(GO:0071599) |
0.1 | 0.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 1.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0090672 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.8 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:0043476 | pigment accumulation(GO:0043476) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.1 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.4 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 2.7 | GO:0071773 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 11.4 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 1.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0072608 | interleukin-10 secretion(GO:0072608) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 1.4 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.0 | GO:0097205 | renal filtration(GO:0097205) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 27.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.0 | 1.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.0 | GO:1901658 | glycosyl compound catabolic process(GO:1901658) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.0 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.8 | 32.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
10.1 | 30.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
6.9 | 20.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
6.9 | 41.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
5.2 | 36.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
5.0 | 15.1 | GO:0048179 | activin receptor complex(GO:0048179) |
4.7 | 14.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
4.6 | 36.8 | GO:0043083 | synaptic cleft(GO:0043083) |
4.2 | 4.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
4.0 | 16.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.9 | 11.8 | GO:0072534 | perineuronal net(GO:0072534) |
3.7 | 11.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.7 | 22.3 | GO:0005915 | zonula adherens(GO:0005915) |
3.7 | 22.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.6 | 14.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
3.4 | 3.4 | GO:0097513 | myosin II filament(GO:0097513) |
3.4 | 47.4 | GO:0033268 | node of Ranvier(GO:0033268) |
3.3 | 23.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
3.3 | 3.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
3.1 | 9.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
3.1 | 9.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
3.0 | 29.7 | GO:0060091 | kinocilium(GO:0060091) |
3.0 | 3.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
2.9 | 8.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
2.9 | 2.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.9 | 17.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
2.7 | 10.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
2.7 | 8.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.6 | 10.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.5 | 7.6 | GO:0032280 | symmetric synapse(GO:0032280) |
2.5 | 7.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.5 | 12.5 | GO:0070695 | FHF complex(GO:0070695) |
2.5 | 22.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.4 | 4.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
2.4 | 7.2 | GO:0045298 | tubulin complex(GO:0045298) |
2.4 | 7.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.4 | 11.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.3 | 23.4 | GO:0031527 | filopodium membrane(GO:0031527) |
2.3 | 9.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.3 | 32.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.2 | 20.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.2 | 6.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.2 | 15.6 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
2.2 | 6.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.2 | 6.5 | GO:0071942 | XPC complex(GO:0071942) |
2.1 | 25.3 | GO:0034706 | sodium channel complex(GO:0034706) |
2.1 | 8.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.1 | 4.2 | GO:0030904 | retromer complex(GO:0030904) |
2.1 | 12.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
2.0 | 100.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
2.0 | 10.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.0 | 6.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.0 | 2.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
2.0 | 6.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.0 | 85.2 | GO:0043198 | dendritic shaft(GO:0043198) |
1.9 | 5.7 | GO:0097433 | dense body(GO:0097433) |
1.9 | 1.9 | GO:0044393 | microspike(GO:0044393) |
1.9 | 18.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.8 | 7.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.8 | 5.5 | GO:0097427 | microtubule bundle(GO:0097427) |
1.8 | 18.3 | GO:0031512 | motile primary cilium(GO:0031512) |
1.8 | 9.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.8 | 3.6 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.8 | 9.1 | GO:0042629 | mast cell granule(GO:0042629) |
1.8 | 19.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.8 | 5.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.7 | 38.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.7 | 24.3 | GO:0031045 | dense core granule(GO:0031045) |
1.7 | 10.3 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.7 | 5.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.7 | 11.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.7 | 5.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.7 | 6.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.7 | 13.4 | GO:0031209 | SCAR complex(GO:0031209) |
1.7 | 10.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.7 | 19.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.6 | 6.5 | GO:0000322 | storage vacuole(GO:0000322) |
1.6 | 6.5 | GO:0030478 | actin cap(GO:0030478) |
1.6 | 4.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.6 | 4.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.6 | 4.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.5 | 4.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.5 | 6.1 | GO:0071817 | MMXD complex(GO:0071817) |
1.5 | 13.7 | GO:0032433 | filopodium tip(GO:0032433) |
1.5 | 9.1 | GO:0030897 | HOPS complex(GO:0030897) |
1.5 | 10.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.5 | 3.0 | GO:0043194 | axon initial segment(GO:0043194) |
1.5 | 3.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.5 | 25.3 | GO:0005614 | interstitial matrix(GO:0005614) |
1.5 | 4.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.5 | 1.5 | GO:0035838 | growing cell tip(GO:0035838) |
1.5 | 1.5 | GO:0042827 | platelet dense granule(GO:0042827) |
1.5 | 19.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.5 | 16.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.5 | 10.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.5 | 8.7 | GO:0002177 | manchette(GO:0002177) |
1.4 | 2.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.4 | 2.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.4 | 10.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.4 | 7.2 | GO:0070852 | cell body fiber(GO:0070852) |
1.4 | 22.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.4 | 11.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.4 | 5.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.4 | 2.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.4 | 1.4 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
1.3 | 126.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
1.3 | 6.5 | GO:0005579 | membrane attack complex(GO:0005579) |
1.3 | 3.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.3 | 57.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.3 | 3.8 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 7.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.3 | 2.5 | GO:0005883 | neurofilament(GO:0005883) |
1.2 | 4.9 | GO:0035363 | histone locus body(GO:0035363) |
1.2 | 30.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.2 | 10.9 | GO:0005869 | dynactin complex(GO:0005869) |
1.2 | 3.6 | GO:0036396 | MIS complex(GO:0036396) |
1.2 | 3.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.2 | 158.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.2 | 3.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.2 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.2 | 9.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 6.9 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.1 | 1.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.1 | 4.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.1 | 1.1 | GO:0030286 | dynein complex(GO:0030286) |
1.1 | 2.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.1 | 2.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.1 | 3.3 | GO:1990357 | terminal web(GO:1990357) |
1.1 | 4.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.1 | 5.5 | GO:0032009 | early phagosome(GO:0032009) |
1.1 | 15.3 | GO:0033391 | chromatoid body(GO:0033391) |
1.1 | 3.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.1 | 4.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 4.3 | GO:0097449 | astrocyte projection(GO:0097449) |
1.1 | 4.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.1 | 3.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.1 | 11.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
1.1 | 4.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.0 | 2.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.0 | 8.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.0 | 1.0 | GO:0044453 | nuclear membrane part(GO:0044453) |
1.0 | 3.9 | GO:1990745 | EARP complex(GO:1990745) |
1.0 | 6.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.0 | 6.8 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.0 | 7.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.0 | 13.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.0 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.0 | 1.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.9 | 11.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.9 | 3.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.9 | 2.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 1.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.9 | 3.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.9 | 3.7 | GO:0043196 | varicosity(GO:0043196) |
0.9 | 2.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.9 | 13.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.9 | 6.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.9 | 8.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.9 | 3.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.9 | 35.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.9 | 3.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.9 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.8 | 6.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 65.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.8 | 3.4 | GO:0098590 | plasma membrane region(GO:0098590) |
0.8 | 11.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.8 | 12.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 5.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 14.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.8 | 2.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.8 | 3.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.8 | 19.2 | GO:0030424 | axon(GO:0030424) |
0.8 | 2.4 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.8 | 5.6 | GO:0046930 | pore complex(GO:0046930) |
0.8 | 2.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.8 | 3.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.8 | 1.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.8 | 2.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.8 | 61.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.8 | 7.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.8 | 2.4 | GO:0071547 | piP-body(GO:0071547) |
0.8 | 3.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.8 | 9.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.8 | 8.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.8 | 3.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.8 | 3.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 1.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.8 | 43.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.8 | 2.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.8 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.8 | 6.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.8 | 2.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.8 | 9.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.8 | 3.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.8 | 7.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 97.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 7.5 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 1.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 8.9 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.7 | 2.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 0.7 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.7 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 2.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.7 | 5.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.7 | 1.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.7 | 2.9 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 28.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 2.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.7 | 5.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.7 | 16.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.7 | 20.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 1.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.7 | 2.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.7 | 2.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.7 | 2.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 0.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.7 | 4.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.7 | 1.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.7 | 10.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.7 | 17.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.7 | 9.1 | GO:0030057 | desmosome(GO:0030057) |
0.7 | 2.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.6 | 14.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.6 | 6.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.6 | 1.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.6 | 1.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.6 | 5.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.6 | 26.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.6 | 4.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.6 | 8.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 32.7 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 17.0 | GO:0005921 | gap junction(GO:0005921) |
0.6 | 1.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 1.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.6 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 2.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 9.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.6 | 0.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.6 | 5.4 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.6 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 1.8 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 4.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 1.2 | GO:0033503 | HULC complex(GO:0033503) |
0.6 | 15.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.6 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 2.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 5.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 1.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 6.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.6 | 0.6 | GO:0005818 | aster(GO:0005818) |
0.6 | 10.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.6 | 484.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.6 | 155.1 | GO:0005929 | cilium(GO:0005929) |
0.6 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 1.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.6 | 26.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.6 | 1.7 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 4.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.6 | 1.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 5.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 7.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 9.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.5 | 20.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 6.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.5 | 2.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 5.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 5.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.5 | 5.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 3.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.5 | 4.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 1.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 1.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 2.0 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 16.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.5 | 1.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 4.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 1.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 1.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 1.5 | GO:0000802 | transverse filament(GO:0000802) |
0.5 | 3.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 0.5 | GO:0042627 | chylomicron(GO:0042627) |
0.5 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.5 | 32.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.5 | 1.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 2.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 1.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.5 | 7.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.5 | 1.4 | GO:0032806 | holo TFIIH complex(GO:0005675) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.5 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 21.2 | GO:0043235 | receptor complex(GO:0043235) |
0.5 | 1.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 4.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.5 | 5.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.5 | 2.7 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.5 | 20.4 | GO:0005884 | actin filament(GO:0005884) |
0.5 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 2.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 3.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.4 | 0.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 55.3 | GO:0045202 | synapse(GO:0045202) |
0.4 | 1.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.4 | 1.3 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 1.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.4 | 1.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 2.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 1.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 1.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 1.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 11.2 | GO:0005814 | centriole(GO:0005814) |
0.4 | 2.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 3.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 0.8 | GO:0030118 | clathrin coat(GO:0030118) |
0.4 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 6.7 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 17.6 | GO:0005770 | late endosome(GO:0005770) |
0.4 | 5.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 0.8 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.4 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 6.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.4 | 7.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 52.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.4 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 2.3 | GO:0070187 | telosome(GO:0070187) |
0.4 | 7.8 | GO:0031253 | cell projection membrane(GO:0031253) |
0.4 | 126.4 | GO:0009986 | cell surface(GO:0009986) |
0.4 | 2.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 6.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 3.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 3.5 | GO:0001741 | XY body(GO:0001741) |
0.4 | 7.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 1.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 1.7 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 2.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.3 | 5.6 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 15.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 2.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 85.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.3 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 3.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 3.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 17.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 4.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.3 | 3.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 1.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 52.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 1.0 | GO:0044297 | cell body(GO:0044297) |
0.3 | 17.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 2.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 1.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 2.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 3.0 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.3 | 0.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 26.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.3 | 0.9 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 1.7 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 1.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.3 | 28.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 161.4 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.3 | 2.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 2.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.3 | 15.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 2.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 3.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.9 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 1.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 2.9 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.2 | 142.5 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 7.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.7 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 0.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 515.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 11.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 3.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 2.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.9 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 3.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 1.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.9 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 1.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 2.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 17.3 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 4.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 1.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 3.1 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 67.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 74.7 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 3.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 4.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.0 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 1.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
9.9 | 39.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
9.3 | 27.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
8.2 | 24.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
6.3 | 31.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.5 | 16.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
5.5 | 22.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
5.3 | 15.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.3 | 10.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
5.2 | 5.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
5.2 | 20.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
5.1 | 15.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
5.1 | 20.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
5.0 | 19.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
4.8 | 19.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
4.7 | 14.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
4.6 | 13.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
4.6 | 18.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
4.6 | 13.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.5 | 17.9 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
4.4 | 13.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.3 | 12.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
4.3 | 8.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
4.3 | 17.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.2 | 12.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
4.1 | 16.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
4.1 | 24.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.0 | 15.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
3.9 | 11.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.9 | 7.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
3.8 | 15.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
3.7 | 15.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
3.7 | 14.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
3.7 | 14.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
3.6 | 3.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
3.6 | 3.6 | GO:0038191 | neuropilin binding(GO:0038191) |
3.6 | 14.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
3.5 | 17.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.4 | 13.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
3.4 | 3.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
3.3 | 16.6 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
3.3 | 16.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
3.2 | 9.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
3.2 | 15.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.1 | 47.2 | GO:0031402 | sodium ion binding(GO:0031402) |
3.1 | 18.8 | GO:0034711 | inhibin binding(GO:0034711) |
3.1 | 9.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
3.0 | 20.8 | GO:0018647 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.9 | 20.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
2.9 | 8.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.9 | 72.2 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
2.8 | 11.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.8 | 11.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.8 | 14.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.7 | 11.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.7 | 8.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.7 | 10.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.7 | 10.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.7 | 10.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.7 | 18.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.6 | 7.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.6 | 12.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.6 | 7.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.5 | 38.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
2.5 | 10.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.5 | 7.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.5 | 7.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
2.5 | 2.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.4 | 7.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
2.3 | 7.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.3 | 16.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.3 | 11.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.3 | 4.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
2.3 | 6.9 | GO:0051425 | PTB domain binding(GO:0051425) |
2.3 | 29.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.3 | 32.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
2.3 | 15.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.3 | 4.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
2.3 | 29.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.2 | 22.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
2.2 | 6.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
2.2 | 24.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
2.2 | 6.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.2 | 13.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.2 | 2.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.2 | 17.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.2 | 10.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
2.2 | 8.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.1 | 10.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.1 | 12.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
2.1 | 10.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
2.1 | 12.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.1 | 2.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
2.1 | 6.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
2.0 | 12.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
2.0 | 14.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.0 | 18.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.0 | 8.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.0 | 2.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.9 | 5.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.9 | 7.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.9 | 52.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.9 | 13.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.9 | 7.5 | GO:0030984 | kininogen binding(GO:0030984) |
1.9 | 1.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.9 | 22.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.9 | 59.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.8 | 25.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.8 | 5.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
1.8 | 11.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.8 | 10.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.8 | 5.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.8 | 21.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.8 | 7.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.8 | 5.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.8 | 5.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.8 | 21.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.8 | 45.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.8 | 7.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.7 | 22.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.7 | 5.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.7 | 1.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.7 | 5.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.7 | 5.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.7 | 5.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.7 | 3.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.7 | 5.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.7 | 6.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.7 | 5.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.6 | 3.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.6 | 4.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.6 | 34.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.6 | 8.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.6 | 4.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.6 | 1.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.6 | 8.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.6 | 6.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.6 | 18.9 | GO:0015643 | toxic substance binding(GO:0015643) |
1.6 | 9.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.6 | 25.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
1.6 | 7.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.6 | 6.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.5 | 29.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.5 | 4.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.5 | 6.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.5 | 9.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.5 | 4.6 | GO:0048185 | activin binding(GO:0048185) |
1.5 | 27.3 | GO:0005112 | Notch binding(GO:0005112) |
1.5 | 19.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.5 | 6.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.5 | 5.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.5 | 8.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.5 | 4.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.5 | 5.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.5 | 7.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.5 | 4.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.5 | 2.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.5 | 1.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
1.5 | 4.4 | GO:0071253 | connexin binding(GO:0071253) |
1.4 | 20.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.4 | 15.7 | GO:0030276 | clathrin binding(GO:0030276) |
1.4 | 17.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.4 | 2.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.4 | 4.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.4 | 4.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.4 | 12.5 | GO:0070513 | death domain binding(GO:0070513) |
1.4 | 5.5 | GO:0070052 | collagen V binding(GO:0070052) |
1.4 | 5.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.4 | 4.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.4 | 4.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.4 | 6.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.4 | 12.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.3 | 2.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.3 | 22.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.3 | 1.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.3 | 4.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.3 | 5.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.3 | 1.3 | GO:0032564 | dATP binding(GO:0032564) |
1.3 | 32.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.3 | 3.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.3 | 27.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.3 | 10.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.3 | 16.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.3 | 10.3 | GO:0039706 | co-receptor binding(GO:0039706) |
1.3 | 6.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.3 | 10.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.3 | 6.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.3 | 7.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.3 | 8.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.2 | 6.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
1.2 | 3.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.2 | 3.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.2 | 1.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.2 | 19.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.2 | 16.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
1.2 | 12.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.2 | 3.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.2 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.2 | 2.4 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 11.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.2 | 24.7 | GO:0030332 | cyclin binding(GO:0030332) |
1.2 | 62.3 | GO:0017022 | myosin binding(GO:0017022) |
1.2 | 5.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.2 | 2.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.2 | 3.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.2 | 8.1 | GO:0008494 | translation activator activity(GO:0008494) |
1.1 | 3.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.1 | 8.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.1 | 2.3 | GO:0000339 | RNA cap binding(GO:0000339) |
1.1 | 7.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.1 | 3.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.1 | 9.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.1 | 10.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.1 | 3.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.1 | 4.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.1 | 4.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.1 | 4.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.1 | 29.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.1 | 6.6 | GO:0042805 | actinin binding(GO:0042805) |
1.1 | 3.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.1 | 2.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.1 | 2.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.1 | 6.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.1 | 3.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.1 | 4.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.1 | 7.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.1 | 26.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 3.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.0 | 5.2 | GO:0017040 | ceramidase activity(GO:0017040) |
1.0 | 25.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.0 | 3.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.0 | 11.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.0 | 1.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.0 | 7.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.0 | 10.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
1.0 | 2.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 1.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
1.0 | 3.0 | GO:0019862 | IgA binding(GO:0019862) |
1.0 | 4.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.0 | 8.0 | GO:0019841 | retinol binding(GO:0019841) |
1.0 | 18.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.0 | 18.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.0 | 3.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.0 | 14.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.0 | 1.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 4.9 | GO:0016595 | glutamate binding(GO:0016595) |
1.0 | 4.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.0 | 12.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.0 | 3.9 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 3.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.0 | 3.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.0 | 11.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.0 | 2.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 2.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.0 | 5.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.0 | 5.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.0 | 9.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.0 | 5.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.0 | 4.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.0 | 4.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.9 | 4.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.9 | 2.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.9 | 11.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.9 | 1.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.9 | 2.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.9 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.9 | 6.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 1.8 | GO:0035276 | ethanol binding(GO:0035276) |
0.9 | 9.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.9 | 24.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.9 | 10.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.9 | 18.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 10.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.9 | 1.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.9 | 6.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.9 | 4.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.9 | 5.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 2.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.9 | 3.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.9 | 5.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.9 | 1.8 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.9 | 3.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.9 | 19.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.9 | 2.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.9 | 2.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.9 | 3.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.9 | 7.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.9 | 17.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.9 | 2.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.9 | 6.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.9 | 12.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.9 | 2.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.9 | 3.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.8 | 4.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 6.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 0.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 42.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.8 | 2.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.8 | 5.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.8 | 1.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.8 | 2.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.8 | 3.3 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 5.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.8 | 0.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.8 | 7.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 8.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.8 | 4.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.8 | 5.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.8 | 4.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.8 | 3.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.8 | 1.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.8 | 3.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 0.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.8 | 3.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 6.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.8 | 3.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 4.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.8 | 21.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.8 | 0.8 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.8 | 2.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 3.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 5.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.8 | 2.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.8 | 2.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.8 | 6.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.7 | 9.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.7 | 2.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 3.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.7 | 72.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.7 | 3.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 5.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.7 | 0.7 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.7 | 1.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 3.7 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.7 | 7.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.7 | 1.5 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.7 | 2.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 2.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.7 | 2.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 2.2 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 2.9 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.7 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.7 | 4.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.7 | 5.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 0.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.7 | 2.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.7 | 7.8 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.7 | 2.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 0.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 1.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 2.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.7 | 2.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 19.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.7 | 5.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.7 | 4.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.7 | 2.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.7 | 15.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.7 | 4.1 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.7 | 2.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 2.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.7 | 6.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.7 | 1.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.7 | 3.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.7 | 10.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.7 | 2.7 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.7 | 5.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.7 | 12.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 6.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.7 | 2.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 7.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 1.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 7.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.6 | 1.9 | GO:0071949 | FAD binding(GO:0071949) |
0.6 | 6.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.6 | 5.1 | GO:0052773 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.6 | 29.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.6 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 2.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 1.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.6 | 3.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 1.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 3.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 1.9 | GO:0032052 | bile acid binding(GO:0032052) |
0.6 | 12.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 1.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 1.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 3.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.6 | 2.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 9.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.6 | 1.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.6 | 6.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 1.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 2.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.6 | 2.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.6 | 11.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.6 | 12.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 15.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 3.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 7.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 3.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 4.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 6.5 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.6 | 1.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 2.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 2.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 4.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 2.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.6 | 1.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.6 | 7.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.6 | 10.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 1.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.6 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 8.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 4.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.6 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.6 | 2.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 1.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.6 | 1.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.6 | 5.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.6 | 2.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 2.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.6 | 0.6 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.6 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.6 | 1.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 1.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.6 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 5.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.5 | 6.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.5 | 2.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.5 | 11.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 1.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 0.5 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.5 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 8.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.5 | 2.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.5 | 13.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.5 | 15.6 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 14.5 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.5 | 1.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.5 | 2.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.5 | 4.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 1.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 1.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 1.5 | GO:0001846 | opsonin binding(GO:0001846) complement component C1q binding(GO:0001849) |
0.5 | 2.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.5 | 7.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 0.5 | GO:0033265 | choline binding(GO:0033265) |
0.5 | 1.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 16.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.5 | 11.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.5 | 7.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.5 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 4.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 6.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 3.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.5 | 2.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.5 | 19.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.5 | 5.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 4.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 0.5 | GO:0015927 | trehalase activity(GO:0015927) |
0.5 | 1.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 5.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 5.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 4.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 6.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 1.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 9.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.5 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 12.8 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.5 | 1.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 4.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.5 | 1.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 1.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.5 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 1.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 3.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 1.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.5 | 0.9 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.5 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.5 | 2.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.5 | 4.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 0.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 4.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.4 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 3.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 3.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 2.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 2.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 3.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 2.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 1.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.4 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 1.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 2.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 15.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 1.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 2.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 2.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 3.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 2.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 3.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 2.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 11.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.4 | 1.7 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.4 | 13.3 | GO:0052768 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.4 | 8.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 4.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 4.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.4 | 0.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 6.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.4 | 9.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 0.4 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.4 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 32.3 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.4 | 6.7 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.4 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 0.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 5.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 3.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 4.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 0.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 2.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 0.8 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 7.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 1.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.4 | 14.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 10.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 2.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.4 | 1.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 4.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.4 | 1.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 3.6 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.4 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.8 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 1.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 129.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 1.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.3 | 1.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 3.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 0.3 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.3 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 1.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 1.7 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.3 | 3.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 1.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 3.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 1.0 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.3 | 13.7 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 1.6 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 0.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.3 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 7.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 1.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.3 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 2.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 1.8 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.3 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 3.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 11.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 0.3 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.3 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.3 | 0.3 | GO:0030545 | receptor regulator activity(GO:0030545) |
0.3 | 1.5 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.3 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 0.3 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.3 | 0.6 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 31.3 | GO:0003729 | mRNA binding(GO:0003729) |
0.3 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 3.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 4.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 1.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 1.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 5.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 0.3 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.3 | 1.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 9.1 | GO:0019955 | cytokine binding(GO:0019955) |
0.3 | 1.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.3 | 19.3 | GO:0005179 | hormone activity(GO:0005179) |
0.3 | 2.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 9.9 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.3 | 1.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 1.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 0.8 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 1.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 48.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 2.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 10.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 5.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 9.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 0.5 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.2 | 0.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 2.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 16.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 17.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 31.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 8.0 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 3.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.2 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 5.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 5.6 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 77.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 1.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 2.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.6 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 5.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 4.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 7.9 | GO:0015293 | symporter activity(GO:0015293) |
0.2 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.2 | 1.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 1.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 2.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 6.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 2.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.6 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 42.3 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 8.7 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 3.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.1 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.1 | 1.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 5.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 6.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.4 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.1 | 10.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 4.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 1.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 2.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0034925 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 1.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 1.4 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 8.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 3.0 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 5.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 3.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.2 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 1.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 0.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 7.6 | PID REELIN PATHWAY | Reelin signaling pathway |
4.2 | 12.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
3.4 | 3.4 | PID IGF1 PATHWAY | IGF1 pathway |
2.2 | 84.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.1 | 22.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.0 | 16.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.7 | 25.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.7 | 1.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.6 | 1.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.6 | 6.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.5 | 5.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.4 | 4.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.4 | 13.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.3 | 81.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.3 | 32.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.3 | 6.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.3 | 25.3 | PID ALK1 PATHWAY | ALK1 signaling events |
1.2 | 33.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.1 | 5.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.1 | 2.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.1 | 13.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.1 | 10.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.1 | 2.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.1 | 6.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.0 | 15.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.0 | 34.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.0 | 21.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.0 | 3.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 10.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 6.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.9 | 36.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.9 | 19.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.9 | 6.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 23.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.9 | 6.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 35.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.8 | 33.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.8 | 7.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.8 | 11.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 26.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 5.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.7 | 16.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.7 | 99.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 117.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.7 | 13.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.7 | 11.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.7 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 9.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.7 | 3.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.7 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 174.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.7 | 7.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 14.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 1.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.6 | 11.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.6 | 1.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 7.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 7.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 5.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 8.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.5 | 2.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 2.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 9.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 3.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 8.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 1.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 8.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 89.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.4 | 15.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 3.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 1.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 2.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 7.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 6.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 2.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 3.9 | PID ATM PATHWAY | ATM pathway |
0.3 | 3.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 4.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 6.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 3.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 3.2 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 4.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 8.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 7.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 5.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 6.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 1.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 8.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 5.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
4.5 | 13.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.7 | 11.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
3.6 | 51.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.1 | 42.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.0 | 3.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
2.8 | 25.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.8 | 30.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.7 | 71.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
2.7 | 56.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.7 | 18.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.6 | 41.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
2.5 | 20.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
2.3 | 81.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.1 | 30.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.0 | 2.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.8 | 46.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.8 | 12.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.7 | 15.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.7 | 23.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.7 | 18.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.6 | 1.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.6 | 17.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.6 | 84.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.6 | 18.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.6 | 36.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.6 | 17.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.5 | 19.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.5 | 16.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.5 | 11.8 | REACTOME OPSINS | Genes involved in Opsins |
1.5 | 17.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.4 | 25.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.4 | 18.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.4 | 26.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.4 | 16.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.4 | 1.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.3 | 21.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.3 | 18.5 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
1.3 | 18.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.3 | 2.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.3 | 13.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.3 | 18.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 2.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.3 | 23.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.3 | 31.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.3 | 2.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.2 | 19.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.2 | 7.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.2 | 22.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.2 | 82.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.2 | 5.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
1.2 | 38.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.2 | 1.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.2 | 1.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.2 | 16.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.1 | 26.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 8.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 10.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
1.1 | 6.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.1 | 8.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.1 | 3.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
1.1 | 11.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.0 | 1.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.0 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.0 | 2.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.0 | 62.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.0 | 19.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
1.0 | 15.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 4.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.0 | 8.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.0 | 11.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.9 | 12.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.9 | 4.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.9 | 15.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.9 | 11.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 11.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.9 | 23.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.9 | 5.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.9 | 13.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 5.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.9 | 12.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.9 | 18.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.9 | 3.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.9 | 131.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.8 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 4.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.8 | 9.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.8 | 13.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.8 | 14.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.8 | 10.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.8 | 5.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 4.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.8 | 1.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.8 | 15.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.8 | 9.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 61.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.7 | 5.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.7 | 7.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.7 | 7.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.7 | 2.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.7 | 2.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.7 | 4.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 6.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.7 | 7.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 40.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 5.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 11.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 1.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.6 | 22.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.6 | 2.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.6 | 10.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 10.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.6 | 6.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.6 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.6 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.6 | 4.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 2.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 11.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.6 | 16.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.6 | 8.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.6 | 7.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 29.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 3.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 1.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 2.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 29.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 23.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 2.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 10.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.5 | 7.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 0.5 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.5 | 10.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.5 | 6.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.5 | 5.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 0.5 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.5 | 3.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 8.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.5 | 5.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 6.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.5 | 3.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 4.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 1.8 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.4 | 5.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 4.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 10.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 11.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 4.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 6.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 9.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 3.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 7.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 3.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 2.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 4.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 4.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 16.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 5.7 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.4 | 3.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 2.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.4 | 12.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.3 | 7.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 2.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 5.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 2.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 2.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 1.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 8.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 3.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 4.7 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 19.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 12.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 0.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 2.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 0.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 2.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 3.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 7.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 3.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.3 | 5.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 1.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 1.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 2.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 7.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 5.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 10.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 1.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 12.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 1.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 1.5 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 14.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.2 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.1 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 2.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 1.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |